News

According to the company, the GemStar SP infusion system is designed to help caregivers incorporate patient safety best practices right at the patient’s bedside. The company said that

Following the restructuring, Trubion will continue to invest in the development of its proprietary program, TRU-016, and the efficient and timely advancement of select preclinical assets that it

As Arca’s CFO and COO, Ms Falberg will be responsible for the company’s accounting, corporate finance, financial planning, treasury and other corporate functions. Ms Falberg will report to

Mr Thurman has been serving as chairman of the board since June 2008 and interim president and CEO since January 2009. Mr Thurman most recently served as chairman

Sales were strong throughout the year. To March 2008 turnover increased 10.9% compared with the previous year, while in the second quarter this increase was 16.8%. The third

Since joining Sanofi-Aventis in the UK in 1994, Mr Steve has achieved significant results for the company in a number of positions including marketing director and business unit

Dr Lander replaces Timothy Freer, the founder of Solis’s predecessor organization, and the first chief medical officer of Solis, who has retired. Dr Lander is the lead physician

In this role, Mr Flounlacker will be responsible for coordinating operations across the company among other senior executives to optimize company resources to achieve training targets, sales and

In this role, Mr Kelley will be responsible for the company’s direct subsidiaries in four European countries, Japan, China and Korea, and for Cynosure distributors covering an additional